Page 47 - Comstock Act News Today

The Supreme Court on Tuesday seemed likely to preserve access to a medication that was used in nearly two-thirds of all abortions in the U.S. last year.

The fate of mifepristone will be considered by the U.S. Supreme Court in its first abortion case since it overturned Roe v. Wade.

The case could affect not just abortion access but oversight of the drug industry and the authority of federal agencies. The court hears arguments Tuesday.

Since 2007, Jezebel has been the Internet's most treasured source for everything celebrities, sex, and politics...with teeth.

The 2014 Supreme Court ruling is even more consequential as we stare down the possibility of Trump’s reelection—and a revival of the Comstock Act.

The Supreme Court’s mifepristone decision could make abortions harder to access and challenge the FDA’s authority to regulate all drugs and devices

WASHINGTON — The Supreme Court hears arguments Tuesday in a challenge that could limit access to a widely used drug for medication abortions, reshape health care policy and upend the

Lawyers from the conservative Christian group that won the case to overturn Roe vs. Wade are returning to the U.S. Supreme Court on Tuesday in pursuit of an urgent priority: Shutting down access to abortion pills for women across the country. The case challenges the FDA’s regulation of mifepristone, a prescription-only drug approved in 2000 […] The post Tomorrow’s abortion case at the Supreme Court: The FDA and a return to an 1873 obscenity law appeared first on Daily Montan...

Lawyers from the conservative Christian group that won the case to overturn Roe v. Wade are returning to the U.S. Supreme Court on Tuesday in pursuit of an urgent priority: shutting down access to abortion pills for women across the country.

A case before the justices challenges the FDA’s regulation of the prescription-only drug approved in 2000 with a stellar safety record that is used in 63% of all U.S. abortions.